Positron Emission Tomography [PET] Scanners Market

Positron Emission Tomography [PET] Scanners Market Summary

The global positron emission tomography [PET] scanners market is expanding steadily, supported by continuous technological advancements, increasing prevalence of chronic diseases, and the growing emphasis on precision diagnostics and personalized medicine in healthcare systems.

Global PET Scanners Market Highlights

• Market Value (2024) US$ 2.2 Bn – A solid baseline driven by rising adoption of advanced molecular imaging systems.
• Forecast Period 2025–2034 – Sustainable growth anticipated with ongoing AI integration and healthcare infrastructure development.
• Expected CAGR 3.2% – Moderate annual expansion supported by digital transformation and hybrid imaging technologies.
• Forecast Value (2034) US$ 3.1 Bn – Reflects the growing clinical relevance and technological sophistication of PET imaging worldwide.

Expert Insights and Strategic Overview

The positron emission tomography (PET) scanners market continues to evolve, driven by the increasing burden of chronic diseases—including cancer, cardiovascular, and neurological disorders—that demand highly sensitive, non-invasive diagnostic imaging solutions.

PET imaging, when fused with other modalities such as CT or MRI, provides unparalleled functional and anatomical detail, enabling clinicians to detect diseases earlier and monitor treatment outcomes more effectively. This fusion technology (PET/CT and PET/MRI) is rapidly becoming the gold standard in diagnostic imaging.

Recent innovations in digital PET technology have transformed imaging performance—offering higher image resolution, faster scan times, and reduced radiation exposure. These developments enhance patient safety, comfort, and throughput efficiency.

The integration of artificial intelligence (AI) into PET workflows is streamlining image reconstruction, quantification, and diagnostic interpretation. AI-driven solutions also enable predictive analytics and improve diagnostic accuracy, supporting clinicians in managing complex cases.

In addition, the emergence of portable and compact PET systems is improving accessibility across outpatient, rural, and community care settings. This miniaturization trend, combined with rising research collaborations in radiotracer development, is broadening PET applications beyond traditional oncology into cardiology, neurology, and molecular imaging.

Leading market participants are pursuing strategic alliances, acquisitions, and partnerships with research institutions to advance hybrid imaging technologies and AI-powered diagnostic solutions that enhance precision medicine and healthcare efficiency.

Market Introduction

Positron Emission Tomography (PET) scanners are advanced diagnostic imaging systems that visualize metabolic processes within the human body by detecting gamma rays emitted from injected radiotracers. Unlike structural imaging techniques, PET imaging provides functional and molecular-level insights, enabling early detection and precise disease characterization.

PET scanners are widely utilized in oncology, cardiology, and neurology, supporting tumor staging, cardiac viability assessment, and neurological disorder evaluation (e.g., Alzheimer’s, Parkinson’s, and epilepsy).

The technology’s ability to quantify biochemical changes at the cellular level makes PET an indispensable diagnostic tool for personalized medicine and drug development. The integration of AI and digital imaging continues to enhance workflow automation, image quality, and diagnostic precision, ensuring PET remains vital in next-generation healthcare diagnostics.

Key Market Drivers

Rising Prevalence of Chronic Diseases Driving PET Scanner Adoption

The global surge in chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has intensified demand for accurate diagnostic imaging. PET scanners provide superior metabolic insights that are essential for early detection, disease staging, and treatment monitoring.

In oncology, PET imaging accurately assesses tumor metabolism and treatment response, while in cardiology, it evaluates myocardial viability and perfusion. Similarly, PET imaging plays a crucial role in diagnosing neurodegenerative disorders.

According to the World Health Organization (WHO), noncommunicable diseases accounted for approximately 43 million deaths in 2021, representing 75% of global non-pandemic deaths. The increasing need for precise diagnostics is thus propelling PET scanner adoption worldwide.

Growing Demand for Personalized Medicine Accelerating Market Growth

Personalized medicine focuses on tailoring treatment strategies based on a patient’s unique biological characteristics. PET imaging supports this paradigm by providing real-time visualization of physiological and molecular processes, enabling targeted therapy planning.

In oncology and cardiology, PET imaging assists in individualized treatment selection and monitoring therapeutic effectiveness. The expansion of personalized medicine initiatives worldwide is expected to significantly boost demand for PET scanners as essential tools for patient-specific care optimization.

PET/CT Scanners Leading the Global PET Scanners Market

Hybrid PET/CT scanners hold the largest market share, owing to their ability to integrate metabolic (PET) and structural (CT) imaging into a single scan. This dual functionality enhances diagnostic precision, improves lesion localization, and allows accurate disease staging and treatment evaluation.

In oncology, PET/CT systems enable clinicians to assess tumor biology and treatment response with greater confidence, reducing diagnostic uncertainty and improving clinical outcomes.

The growing preference for hybrid imaging solutions highlights a shift toward comprehensive, high-efficiency diagnostic systems that support both clinical and research applications.

Regional Outlook

North America dominated the global PET scanners market in 2024 and is projected to maintain its leadership through 2025–2034. The region’s growth is driven by its advanced healthcare infrastructure, high adoption of hybrid and digital imaging technologies, and strong emphasis on early disease detection.

Supportive reimbursement frameworks, substantial investments in R&D, and a robust base of global manufacturers—such as GE HealthCare, Siemens Healthineers, and Philips—further reinforce North America’s market dominance.

Competitive Landscape

Leading manufacturers are focusing on innovation in digital PET systems, AI integration, and hybrid imaging solutions (PET/CT and PET/MRI). Strategic collaborations with academic and research institutions are fostering advancements in radiotracer development and software-driven imaging technologies.

Prominent Companies Operating in the Global Market

• GE HealthCare
• Siemens Healthcare Private Limited
• CANON MEDICAL SYSTEMS CORPORATION
• United Imaging Healthcare Co., Ltd.
• Koninklijke Philips N.V.
• Mediso Ltd
• Kindsway Biotech
• Neusoft Medical Systems Co., Ltd.
• Bruker
• Shimadzu Corporation
• MinFound Medical Systems Co., Ltd.
• Shenzhen Basda Medical Apparatus Co., Ltd.
• Positrigo AG
• Positron
• SynchroPET

Each company has been profiled based on its product innovation, global footprint, financial performance, and strategic initiatives in the PET scanners industry.

Key Developments in the Market

• June 2025 Shimadzu Corporation received FDA clearance for its PositView PET system designed for head and breast imaging, marking its U.S. market entry with advanced precision capabilities.
• June 2024 Siemens Healthineers launched the Biograph Trinion PET/CT system, a high-performance scanner offering sustainable operation, superior image quality, and expanded clinical applications.

Positron Emission Tomography [PET] Scanners Market Snapshot

Segmentation Overview

By Product Type

• Full Ring PET Scanners
• Partial Ring PET Scanners

By Modality

• Standalone PET Scanners
• PET/CT Scanners
• PET/MRI Scanners

By Application

• Oncology
• Cardiology
• Neurology
• Others (Infectious Diseases, etc.)

By End User

• Hospitals and Ambulatory Surgical Centers
• Diagnostic Imaging Centers
• Others (Academic & Research Institutes, etc.)

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa